Our live blog is following market reaction after the Financial Conduct Authority imposes new rules on CFD derivatives » Read More
Since Trump's victory, rising mortgage rates have made homes the least affordable since the Great Recession.
Jim Cramer spoke with United Technologies CEO Greg Hayes, who says the genie of globalization is not going back in the bottle.
Asian markets bounced back on Tuesday with the central bank in Australia holding its benchmark rate steady.
Some major employers are offering signing bonuses of $100,000.
The judge made the decision after the jury said they could not come to a unanimous verdict, NBC News reports.
These are the stocks posting the largest moves after the bell on Monday, including Amazon, TherapeuticsMD and more.
Donald Trump's tariff threats may be a useful tool to keep jobs from moving out of the country, manufacturing expert Scott Paul says.
There are several tools at Donald Trump's disposal for him follow through on trade threats.
Amazon is also considering at least two types of bigger stores, including a store with curbside pick-up and a drive-through option, The Wall Street Journal reports.
The S&P energy sector has surged more than 22 percent so far in 2016.
Almost 9.4 million Obamacare customers were set to receive nearly $33 billion in tax credits to reduce their monthly health insurance premiums this year.
'Bond-market vigilantes' could make a comeback if some of Trump's policy plans come to fruition, says trader Jack Ablin.
The companies will share "hashes" of extremist content they have removed to enable their peers to identify the same content.
Apple was the only major wearable vendor to see a decline.
Blair sees a common thread from Brexit's passage to Trump's election to support for Philippine President Rodrigo Duterte, USA Today reports.
Donald Trump met with Al Gore, who joined the Apple board in 2003 and as of earlier this year owned a little more than 440,000 shares.
CEO David Schenkein explained that concerns for the molecule were specific to an "extremely high dose, a dose that we would never use in patients."
Donald Trump inherits this situation when he becomes president, but here are the statistics of President Obama's record, NBC News reports.
The bill aims to establish the nation's most comprehensive statewide surveillance system to track infections and deaths from drug-resistant pathogens.